The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.

Mark SmallLoïc PerchenetAlex BennettJörg Linder

Published in: Therapeutic advances in respiratory disease (2024)

Our data suggest that diagnostic delay in PAH results from patient- and physician-related factors, which differ across regions and include lack of awareness of PAH on both sides. Development of better screening strategies may help address this barrier to timely PAH diagnosis.

Keyphrases

pulmonary arterial hypertension
end stage renal disease
pulmonary artery
pulmonary hypertension
ejection fraction
polycyclic aromatic hydrocarbons
newly diagnosed
emergency department
chronic kidney disease
primary care
prognostic factors
case report
cross sectional
artificial intelligence